EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease.
Angiogenesis
; 19(3): 297-309, 2016 07.
Article
in En
| MEDLINE
| ID: mdl-27216867
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Myocardial Ischemia
/
Neovascularization, Physiologic
/
Receptor, EphB4
/
Ephrin-B2
Limits:
Animals
/
Humans
Language:
En
Year:
2016
Type:
Article